{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:13:08Z","timestamp":1758049988698,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05154-3","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:12:52Z","timestamp":1750867972000},"page":"13697-13706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PGRN Counteracts the Associations of Abnormal Tau Proteins with Neurodegeneration and Cognitive Decline in Non-demented Adults: A Longitudinal Study"],"prefix":"10.1007","volume":"62","author":[{"given":"Yi-Fan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"2715\u201332","key":"5154_CR1","first-page":"e23","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin MK, Vazquez-Rosa E, Koh Y, Dhar M, Chaubey K, Cintron-Perez CJ et al (2021) Reducing acetylated tau is neuroprotective in brain injury. Cell 184(2715\u201332):e23","journal-title":"Cell"},{"key":"5154_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nchembio.797","volume":"8","author":"SA Yuzwa","year":"2012","unstructured":"Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K et al (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 8:393\u2013399","journal-title":"Nat Chem Biol"},{"key":"5154_CR3","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V et al (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187:6539\u20136549","journal-title":"J Immunol"},{"key":"5154_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Holtzman DM (2017) Glial contributions to neurodegeneration in tauopathies. Mol Neurodegener 12:50","journal-title":"Mol Neurodegener"},{"key":"5154_CR5","doi-asserted-by":"crossref","unstructured":"Xu W, Han SD, Zhang C, Li JQ, Wang YJ, Tan CC, et al. The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases. Sci Adv. 2020;6.","DOI":"10.1126\/sciadv.abb3063"},{"key":"5154_CR6","doi-asserted-by":"crossref","unstructured":"Suarez-Calvet M, Capell A, Araque Caballero MA, Morenas-Rodriguez E, Fellerer K, Franzmeier N, et al. CSF progranulin increases in the course of Alzheimer\u2019s disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med. 2018;10.","DOI":"10.15252\/emmm.201809712"},{"key":"5154_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2021.02.016","volume":"103","author":"W Xu","year":"2021","unstructured":"Xu W, Tan CC, Cao XP, Tan L 2021 Alzheimer\u2019s Disease Neuroimaging I. Neuroinflammation modulates the association of PGRN with cerebral amyloid-beta burden. Neurobiol Aging, 103:52\u20139.","journal-title":"Neurobiol Aging"},{"key":"5154_CR8","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A et al (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 118:2438\u20132447","journal-title":"J Clin Invest"},{"key":"5154_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","volume":"111","author":"J Zhu","year":"2002","unstructured":"Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111:867\u2013878","journal-title":"Cell"},{"key":"5154_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332:478\u2013484","journal-title":"Science"},{"key":"5154_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00401-017-1668-z","volume":"133","author":"H Takahashi","year":"2017","unstructured":"Takahashi H, Klein ZA, Bhagat SM, Kaufman AC, Kostylev MA, Ikezu T et al (2017) Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta Neuropathol 133:785\u2013807","journal-title":"Acta Neuropathol"},{"key":"5154_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1083\/jcb.200712039","volume":"181","author":"P Van Damme","year":"2008","unstructured":"Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J et al (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181:37\u201341","journal-title":"J Cell Biol"},{"key":"5154_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-5-41","volume":"5","author":"BP Chitramuthu","year":"2010","unstructured":"Chitramuthu BP, Baranowski DC, Kay DG, Bateman A, Bennett HP (2010) Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol Neurodegener 5:41","journal-title":"Mol Neurodegener"},{"key":"5154_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s13238-010-0067-1","volume":"1","author":"X Gao","year":"2010","unstructured":"Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A et al (2010) Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta. Protein Cell 1:552\u2013562","journal-title":"Protein Cell"},{"key":"5154_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A et al (2012) Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav 6:502\u2013516","journal-title":"Brain Imaging Behav"},{"key":"5154_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","volume":"6","author":"LE Gibbons","year":"2012","unstructured":"Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P et al (2012) A composite score for executive functioning, validated in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav 6:517\u2013527","journal-title":"Brain Imaging Behav"},{"key":"5154_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562","journal-title":"Alzheimers Dement"},{"key":"5154_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1523\/JNEUROSCI.5757-10.2011","volume":"31","author":"A Capell","year":"2011","unstructured":"Capell A, Liebscher S, Fellerer K, Brouwers N, Willem M, Lammich S et al (2011) Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J Neurosci 31:1885\u20131894","journal-title":"J Neurosci"},{"key":"5154_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/aje\/kwv212","volume":"183","author":"A Vivot","year":"2016","unstructured":"Vivot A, Power MC, Glymour MM, Mayeda ER, Benitez A, Spiro A 3rd et al (2016) Jump, hop, or skip: modeling practice effects in studies of determinants of cognitive change in older adults. Am J Epidemiol 183:302\u2013314","journal-title":"Am J Epidemiol"},{"key":"5154_CR20","doi-asserted-by":"crossref","unstructured":"Nabizadeh F, Zafari R, Alzheimer's disease Neuroimaging I. Progranulin and neuropathological features of Alzheimer\u2019s disease: longitudinal study. Aging Clin Exp Res. 2024;36:55.","DOI":"10.1007\/s40520-024-02715-9"},{"key":"5154_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-009-0616-y","volume":"119","author":"SB Naphade","year":"2010","unstructured":"Naphade SB, Kigerl KA, Jakeman LB, Kostyk SK, Popovich PG, Kuret J (2010) Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathol 119:123\u2013133","journal-title":"Acta Neuropathol"},{"key":"5154_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1471-4159.2007.04968.x","volume":"104","author":"JL Eriksen","year":"2008","unstructured":"Eriksen JL, Mackenzie IR (2008) Progranulin: normal function and role in neurodegeneration. J Neurochem 104:287\u2013297","journal-title":"J Neurochem"},{"key":"5154_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.410380414","volume":"38","author":"H Arai","year":"1995","unstructured":"Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N et al (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer\u2019s disease. Ann Neurol 38:649\u2013652","journal-title":"Ann Neurol"},{"key":"5154_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26:231\u2013245","journal-title":"Mol Chem Neuropathol"},{"key":"5154_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128","journal-title":"Lancet Neurol"},{"key":"5154_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA et al (2019) Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol 76:915\u2013924","journal-title":"JAMA Neurol"},{"key":"5154_CR27","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B et al (2012) Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest 122:3955\u20133959","journal-title":"J Clin Invest"},{"key":"5154_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ana.26492","volume":"92","author":"G Lan","year":"2022","unstructured":"Lan G, Cai Y, Li A, Liu Z, Ma S, Guo T et al (2022) Association of presynaptic loss with Alzheimer\u2019s disease and cognitive decline. Ann Neurol 92:1001\u20131015","journal-title":"Ann Neurol"},{"key":"5154_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-7-33","volume":"7","author":"J Gass","year":"2012","unstructured":"Gass J, Lee WC, Cook C, Finch N, Stetler C, Jansen-West K et al (2012) Progranulin regulates neuronal outgrowth independent of sortilin. Mol Neurodegener 7:33","journal-title":"Mol Neurodegener"},{"key":"5154_CR30","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:1008","journal-title":"Front Pharmacol"},{"key":"5154_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/NEN.0b013e3181fc9aea","volume":"69","author":"T Philips","year":"2010","unstructured":"Philips T, De Muynck L, Thu HN, Weynants B, Vanacker P, Dhondt J et al (2010) Microglial upregulation of progranulin as a marker of motor neuron degeneration. J Neuropathol Exp Neurol 69:1191\u20131200","journal-title":"J Neuropathol Exp Neurol"},{"key":"5154_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"5154_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/bies.200900086","volume":"31","author":"A Bateman","year":"2009","unstructured":"Bateman A, Bennett HP (2009) The granulin gene family: from cancer to dementia. BioEssays 31:1245\u20131254","journal-title":"BioEssays"},{"key":"5154_CR34","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s12035-015-9358-0","volume":"53","author":"H Jing","year":"2016","unstructured":"Jing H, Tan MS, Yu JT, Tan L (2016) The role of PGRN in Alzheimer\u2019s disease. Mol Neurobiol 53:4189\u20134196","journal-title":"Mol Neurobiol"},{"key":"5154_CR35","doi-asserted-by":"publisher","first-page":"e2210442120","DOI":"10.1073\/pnas.2210442120","volume":"120","author":"X Zhao","year":"2023","unstructured":"Zhao X, Lin Y, Liou B, Fu W, Jian J, Fannie V et al (2023) PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases. Proc Natl Acad Sci U S A 120:e2210442120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5154_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-023-02578-w","volume":"146","author":"T Zhang","year":"2023","unstructured":"Zhang T, Feng T, Wu K, Guo J, Nana AL, Yang G et al (2023) Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination. Acta Neuropathol 146:97\u2013119","journal-title":"Acta Neuropathol"},{"key":"5154_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/NEN.0000000000000158","volume":"74","author":"M Hosokawa","year":"2015","unstructured":"Hosokawa M, Arai T, Masuda-Suzukake M, Kondo H, Matsuwaki T, Nishihara M et al (2015) Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice. J Neuropathol Exp Neurol 74:158\u2013165","journal-title":"J Neuropathol Exp Neurol"},{"key":"5154_CR38","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1016\/j.febslet.2013.09.024","volume":"587","author":"J Jian","year":"2013","unstructured":"Jian J, Zhao S, Tian Q, Gonzalez-Gugel E, Mundra JJ, Uddin SM et al (2013) Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Lett 587:3428\u20133436","journal-title":"FEBS Lett"},{"key":"5154_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajpath.2010.11.002","volume":"178","author":"F Pickford","year":"2011","unstructured":"Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo JR et al (2011) Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am J Pathol 178:284\u2013295","journal-title":"Am J Pathol"},{"key":"5154_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-019-1994-2","volume":"10","author":"W Yoo","year":"2019","unstructured":"Yoo W, Lee J, Noh KH, Lee S, Jung D, Kabir MH et al (2019) Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death Dis 10:758","journal-title":"Cell Death Dis"},{"key":"5154_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-019-1630-1","volume":"16","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang L, Ndong JC, Hettinghouse A, Sun G, Chen C et al (2019) Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice. J Neuroinflammation 16:238","journal-title":"J Neuroinflammation"},{"key":"5154_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1\u20134","journal-title":"Acta Neuropathol"},{"key":"5154_CR43","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/hmg\/ddt534","volume":"23","author":"WC Lee","year":"2014","unstructured":"Lee WC, Almeida S, Prudencio M, Caulfield TR, Zhang YJ, Tay WM et al (2014) Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency. Hum Mol Genet 23:1467\u20131478","journal-title":"Hum Mol Genet"},{"key":"5154_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12967-023-04251-y","volume":"21","author":"M Kurnellas","year":"2023","unstructured":"Kurnellas M, Mitra A, Schwabe T, Paul R, Arrant AE, Roberson ED et al (2023) Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. J Transl Med 21:387","journal-title":"J Transl Med"},{"issue":"4651\u201368","key":"5154_CR45","first-page":"e25","volume":"184","author":"T Logan","year":"2021","unstructured":"Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS et al (2021) Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. Cell 184(4651\u201368):e25","journal-title":"Cell"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05154-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:02:59Z","timestamp":1757790179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05154-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5154"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05154-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ADNI was approved by institutional review boards of all participating institutions, and written informed consent was obtained from all participants according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}